Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial.
AIMS: Unexplained chronic cough is a common condition with no satisfactory treatments. Previous work has suggested that cough may be linked to neutrophilic airway inflammation. This study tested the hypothesis that long-term low-dose erythromycin reduces the induced sputum neutrophil count and 24 h...
Main Authors: | Yousaf, N, Monteiro, W, Parker, D, Matos, S, Birring, S, Pavord, I |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
The long term outcome of patients with unexplained chronic cough.
by: Yousaf, N, et al.
Published: (2013) -
Cough frequency in health and disease.
by: Yousaf, N, et al.
Published: (2013) -
Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
by: Morice, A, et al.
Published: (2017) -
Cough
by: Birring, S, et al.
Published: (2012) -
Cough
by: Birring, S, et al.
Published: (2008)